Mediwound Stock Performance
| MDWD Stock | USD 17.85 0.02 0.11% |
The company secures a Beta (Market Risk) of 0.59, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Mediwound's returns are expected to increase less than the market. However, during the bear market, the loss of holding Mediwound is expected to be smaller as well. At this point, Mediwound has a negative expected return of -0.0015%. Please make sure to verify Mediwound's downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to decide if Mediwound performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Mediwound has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Mediwound is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Actual Historical Performance (%)
One Day Return 3.47 | Five Day Return 2.52 | Year To Date Return (2.99) | Ten Year Return (64.15) | All Time Return (85.22) |
Last Split Factor 1:7 | Last Split Date 2022-12-20 |
1 | MediWound Reports New Clinical Data Demonstrating NexoBrids Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries | 12/10/2025 |
2 | MediWound Ltd. is a favorite amongst institutional investors who own 52 | 12/19/2025 |
3 | Why MediWound Ltd. stock could be next big winner - July 2025 Closing Moves Accurate EntryExit Alerts - ulpravda.ru | 01/08/2026 |
4 | Vericel Announces Preliminary 2025 Financial Results and Business Updates | 01/13/2026 |
5 | MediWound Share Price Crosses Above 50-Day Moving Average Should You Sell | 02/05/2026 |
6 | MediWound to Report Fourth Quarter and Full Year 2025 Financial Results | 02/19/2026 |
| Begin Period Cash Flow | 11.9 M | |
| Total Cashflows From Investing Activities | -8.4 M |
Mediwound | Build AI portfolio with Mediwound Stock |
Mediwound Relative Risk vs. Return Landscape
If you would invest 1,820 in Mediwound on November 25, 2025 and sell it today you would lose (35.00) from holding Mediwound or give up 1.92% of portfolio value over 90 days. Mediwound is currently does not generate positive expected returns and assumes 2.4663% risk (volatility on return distribution) over the 90 days horizon. In different words, 22% of stocks are less volatile than Mediwound, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Mediwound Target Price Odds to finish over Current Price
The tendency of Mediwound Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 17.85 | 90 days | 17.85 | about 58.79 |
Based on a normal probability distribution, the odds of Mediwound to move above the current price in 90 days from now is about 58.79 (This Mediwound probability density function shows the probability of Mediwound Stock to fall within a particular range of prices over 90 days) .
Mediwound Price Density |
| Price |
Predictive Modules for Mediwound
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Mediwound. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mediwound's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Mediwound Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Mediwound is not an exception. The market had few large corrections towards the Mediwound's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Mediwound, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Mediwound within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.05 | |
β | Beta against Dow Jones | 0.59 | |
σ | Overall volatility | 0.72 | |
Ir | Information ratio | -0.03 |
Mediwound Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Mediwound for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Mediwound can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Mediwound generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 20.22 M. Net Loss for the year was (30.22 M) with profit before overhead, payroll, taxes, and interest of 3.88 M. | |
| Mediwound currently holds about 10.41 M in cash with (13.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31. | |
| Mediwound has a poor financial position based on the latest SEC disclosures | |
| Roughly 63.0% of the company shares are owned by institutional investors | |
| Latest headline from globenewswire.com: MediWound to Report Fourth Quarter and Full Year 2025 Financial Results |
Mediwound Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Mediwound Stock often depends not only on the future outlook of the current and potential Mediwound's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mediwound's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 10 M | |
| Cash And Short Term Investments | 43.2 M |
Mediwound Fundamentals Growth
Mediwound Stock prices reflect investors' perceptions of the future prospects and financial health of Mediwound, and Mediwound fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mediwound Stock performance.
| Return On Equity | -0.49 | ||||
| Return On Asset | -0.17 | ||||
| Profit Margin | (0.98) % | ||||
| Operating Margin | (1.20) % | ||||
| Current Valuation | 178.55 M | ||||
| Shares Outstanding | 12.84 M | ||||
| Price To Earning | 16.58 X | ||||
| Price To Book | 4.57 X | ||||
| Price To Sales | 10.96 X | ||||
| Revenue | 20.22 M | ||||
| Gross Profit | 3.88 M | ||||
| EBITDA | (28.12 M) | ||||
| Net Income | (30.22 M) | ||||
| Cash And Equivalents | 10.41 M | ||||
| Cash Per Share | 0.31 X | ||||
| Total Debt | 6.93 M | ||||
| Debt To Equity | 0.64 % | ||||
| Current Ratio | 1.61 X | ||||
| Book Value Per Share | 3.91 X | ||||
| Cash Flow From Operations | (13.62 M) | ||||
| Earnings Per Share | (1.84) X | ||||
| Market Capitalization | 229.36 M | ||||
| Total Asset | 73.5 M | ||||
| Retained Earnings | (205.05 M) | ||||
| Working Capital | 25.62 M | ||||
| Current Asset | 50.4 M | ||||
| Current Liabilities | 5.21 M | ||||
About Mediwound Performance
By analyzing Mediwound's fundamental ratios, stakeholders can gain valuable insights into Mediwound's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Mediwound has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Mediwound has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 61.27 | 58.21 | |
| Return On Tangible Assets | (0.47) | (0.50) | |
| Return On Capital Employed | (0.47) | (0.50) | |
| Return On Assets | (0.47) | (0.50) | |
| Return On Equity | (1.12) | (1.06) |
Things to note about Mediwound performance evaluation
Checking the ongoing alerts about Mediwound for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Mediwound help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Mediwound generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 20.22 M. Net Loss for the year was (30.22 M) with profit before overhead, payroll, taxes, and interest of 3.88 M. | |
| Mediwound currently holds about 10.41 M in cash with (13.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31. | |
| Mediwound has a poor financial position based on the latest SEC disclosures | |
| Roughly 63.0% of the company shares are owned by institutional investors | |
| Latest headline from globenewswire.com: MediWound to Report Fourth Quarter and Full Year 2025 Financial Results |
- Analyzing Mediwound's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mediwound's stock is overvalued or undervalued compared to its peers.
- Examining Mediwound's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mediwound's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mediwound's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Mediwound's stock. These opinions can provide insight into Mediwound's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Mediwound Stock analysis
When running Mediwound's price analysis, check to measure Mediwound's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mediwound is operating at the current time. Most of Mediwound's value examination focuses on studying past and present price action to predict the probability of Mediwound's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mediwound's price. Additionally, you may evaluate how the addition of Mediwound to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |